One Investor Says Anthropic Would Cost “Less Than Palantir on Sales.” That’s a Problem for Palantir
Anthropic set its IPO range at $70-$78, valuing it at 35x-39x trailing sales, lower than Palantir's 53x. Analysts expect Palantir's revenue growth to slow to 53% by 2027. Anthropic's rapid growth and lower valuation may pressure Palantir's premium. Palantir is profitable, while Anthropic is not yet. Anthropic plans to list on Nasdaq under ticker ANT.
How this was made
The 30-second read
Why it matters
Anthropic's IPO range sets a new benchmark for AI valuations, likely compressing Palantir's premium.
Market read
Fresh IPO details for a high‑profile AI company and valuation comparison to an existing AI player create actionable insight for traders.
What to watch
Potential regulatory scrutiny of AI firms could temper enthusiasm.
Background
The article compares Anthropic's upcoming IPO valuation to Palantir's current multiple, highlighting valuation pressure on Palantir.
Ticker impact
Palantir is compared to Anthropic's IPO valuation, highlighting a higher sales multiple that may pressure its stock.
likely pressure as the market prices in valuation compression
The article emphasizes Palantir's 53x sales multiple versus Anthropic's 35‑39x, creating valuation headwinds.
Anthropic filed its IPO prospectus setting a $70‑$78 price range for 825 million shares, a fresh primary disclosure.
likely upside as investors price in the low‑multiple AI entry
The new IPO range and share count represent a large, high‑profile market event.
Market effects
AI sector valuations may be re‑priced, affecting peers beyond Palantir.
US tech market may see broader sentiment shift ahead of the IPO.
Large AI IPO adds to global AI investment narrative.
Counterpoint
Anthropic's lower multiple may not translate to sustained upside if execution falters.
Key entities
- companyAnthropic
AI lab filing for IPO with $70‑$78 price range.
- companyPalantir Technologies
AI data analytics firm with a 53x sales multiple.
